Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors-Reference-Cited by-同舟云学术

Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors

Published:2020-02-22 Issue:6 Volume:147 Page:1666-1679
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Stalin Jimmy¹,Traboulsi Wael¹,Vivancos‐Stalin Lucie¹,Nollet Marie¹,Joshkon Ahmad¹,Bachelier Richard¹,Guillet Benjamin¹²,Lacroix Romaric¹³,Foucault‐Bertaud Alexandrine¹,Leroyer Aurélie S.¹,Dignat‐George Françoise¹³,Bardin Nathalie¹³,Blot‐Chabaud Marcel¹^ORCID

Affiliation:

1. INSERM, INRAE, C2VN, UFR PharmacieAix‐Marseille University Marseille France

2. CERIMED (European Center of Research in Medical Imaging)Aix‐Marseille University Marseille France

3. AP‐HM, La Conception Hospital Marseille France

Funder

Aix-Marseille Université

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Cancer Research,Oncology

Link